Ralph Kramer
Family Medicine · Stuart, VANPI 1235136920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 25.2% of the total.
Across 197 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$726
- Novo Nordisk$311
- Johnson & Johnson$249
- Amgen$147
- Sunovion Pharmaceuticals Inc.$128
- AstraZeneca$123
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $726 |
| Novo Nordisk | 19 | $311 |
| Johnson & Johnson | 16 | $249 |
| Amgen | 9 | $147 |
| Sunovion Pharmaceuticals Inc. | 9 | $128 |
| AstraZeneca | 9 | $123 |
| Novartis | 6 | $109 |
| Eisai Inc. | 7 | $99 |
| Biohaven Pharmaceuticals, Inc. | 4 | $93 |
| Sanofi-aventis U.S. LLC | 6 | $88 |
| GSK | 6 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $84 |
| Bayer | 3 | $66 |
| Merck | 4 | $64 |
| Abbott | 3 | $61 |
| Pfizer | 4 | $57 |
| Biogen | 3 | $50 |
| Astellas Pharma US Inc | 3 | $41 |
| Lilly USA, LLC | 3 | $41 |
| Genentech USA, Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Neurelis, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Amarin Pharma, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
How this compares
$2,881 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Stuart
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.